• Member Statistics

    • 824,027 Colleagues-to-Date [Sponsored by a generous R&D grant from iMBA, Inc.]
  • David E. Marcinko [Editor-in-Chief]

    As a former Dean and appointed University Professor and Endowed Department Chair, Dr. David Edward Marcinko MBA was a NYSE broker and investment banker for a decade who was respected for his unique perspectives, balanced contrarian thinking and measured judgment to influence key decision makers in strategic education, health economics, finance, investing and public policy management.

    Dr. Marcinko is originally from Loyola University MD, Temple University in Philadelphia and the Milton S. Hershey Medical Center in PA; as well as Oglethorpe University and Emory University in Georgia, the Atlanta Hospital & Medical Center; Kellogg-Keller Graduate School of Business and Management in Chicago, and the Aachen City University Hospital, Koln-Germany. He became one of the most innovative global thought leaders in medical business entrepreneurship today by leveraging and adding value with strategies to grow revenues and EBITDA while reducing non-essential expenditures and improving dated operational in-efficiencies.

    Professor David Marcinko was a board certified surgical fellow, hospital medical staff President, public and population health advocate, and Chief Executive & Education Officer with more than 425 published papers; 5,150 op-ed pieces and over 135+ domestic / international presentations to his credit; including the top ten [10] biggest drug, DME and pharmaceutical companies and financial services firms in the nation. He is also a best-selling Amazon author with 30 published academic text books in four languages [National Institute of Health, Library of Congress and Library of Medicine].

    Dr. David E. Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance”, and a former Certified Financial Planner® who was named “Health Economist of the Year” in 2010. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, economics trade journals and publications [AMA, ADA, APMA, AAOS, Physicians Practice, Investment Advisor, Physician’s Money Digest and MD News] etc.

    Later, Dr. Marcinko was a vital and recruited BOD  member of several innovative companies like Physicians Nexus, First Global Financial Advisors and the Physician Services Group Inc; as well as mentor and coach for Deloitte-Touche and other start-up firms in Silicon Valley, CA.

    As a state licensed life, P&C and health insurance agent; and dual SEC registered investment advisor and representative, Marcinko was Founding Dean of the fiduciary and niche focused CERTIFIED MEDICAL PLANNER® chartered professional designation education program; as well as Chief Editor of the three print format HEALTH DICTIONARY SERIES® and online Wiki Project.

    Dr. David E. Marcinko’s professional memberships included: ASHE, AHIMA, ACHE, ACME, ACPE, MGMA, FMMA, FPA and HIMSS. He was a MSFT Beta tester, Google Scholar, “H” Index favorite and one of LinkedIn’s “Top Cited Voices”.

    Marcinko is “ex-officio” and R&D Scholar-on-Sabbatical for iMBA, Inc. who was recently appointed to the MedBlob® [military encrypted medical data warehouse and health information exchange] Advisory Board.



  • ME-P Information & Content Channels

  • ME-P Archives Silo [2006 – 2020]

  • Ann Miller RN MHA [Managing Editor]

    USNews.com, Reuters.com,
    News Alloy.com,
    and Congress.org

    Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners(TM)

    Product Details

    Product Details

    Product Details


    New "Self-Directed" Study Option SinceJanuary 1st, 2020
  • Most Recent ME-Ps

  • PodiatryPrep.org

    Lower Extremity Trauma
    [Click on Image to Enlarge]

  • ME-P Free Advertising Consultation

    The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]

    Product Details

    Product Details

  • Medical & Surgical e-Consent Forms

  • iMBA R&D Services

    Commission a Subject Matter Expert Report [$2500-$9999]January 1st, 2020
    Medical Clinic Valuations * Endowment Fund Management * Health Capital Formation * Investment Policy Statement Analysis * Provider Contracting & Negotiations * Marketplace Competition * Revenue Cycle Enhancements; and more! HEALTHCARE FINANCIAL INDUSTRIAL COMPLEX
  • iMBA Inc., OFFICES

    Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.

  • ME-P Publishing


    If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].

  • Reader Comments, Quips, Opinions, News & Updates

  • Start-Up Advice for Businesses, DRs and Entrepreneurs

    ImageProxy “Providing Management, Financial and Business Solutions for Modernity”
  • Up-Trending ME-Ps

  • Capitalism and Free Enterprise Advocacy

    Whether you’re a mature CXO, physician or start-up entrepreneur in need of management, financial, HR or business planning information on free markets and competition, the "Medical Executive-Post” is the online place to meet for Capitalism 2.0 collaboration. Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds. THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
  • OIG Fraud Warnings

    Beware of health insurance marketplace scams OIG's Most Wanted Fugitives at oig.hhs.gov

Reversed “Out-Sourced” Primary Care Docs

Medical Talent, Supply-Demand and Global Economics

Staff Writers

A new study from the General Accountability Office [GAO] indicates that the number of US doctors specializing in primary care is falling. 

Now, that’s the bad news, and one wonders if this is a result of the income-gap disparity between generalists and specialists? 


The good news is that the numerical gap is being covered by doctors who move here from other countries.

The report states that there were 22,146 American doctors in residency programs for primary care practice, down from 23,801 in 1995. Meanwhile, the number of international medical graduates training in primary care climbed from 13,025 in 1995 to 15,565 in 2006.  

Ugh!  Did we say “good news?”


The presence of foreign-born physicians goes well beyond primary care. 

For example, one in four new physicians is currently an international medical graduate, according to Sen. Bernie Sanders (I-VT), who spoke at a Senate Health, Education, Labor and Pensions Committee meeting where the report was presented.


And so, is this an example of basic economics 101 in-play, and a modern type of reverse in-sourcing of medical talent? Worker unions, take note.

Institutional info: www.HealthcareFinancials.com

The Jarvik Affair

“What’s up with That?”

By Patrick C. Cox, Jr 

Join Our Mailing List 

How many times have you viewed the Lipitor® “educational” commercial featuring Dr. Robert Jarvik?  

If you are like me, probably often since Pfizer appears set on getting their money’s worth from the production. The spot pops up everywhere it seems. Pretty impressive with the rowing, the lake, and natural beauty along with a heartfelt pitch from Jarvik on what a difference Lipitor® has made in his life.

He shares his thoughts that Lipitor® is one of the most researched drugs and he’s glad that he takes it as a doctor, and a dad. 

Well, the commercial may have run one time too many.  Questions have been raised by consumers and now congressional figures as to Jarvik’s credibility and his Lipitor® endorsement.

For example, he never pursued a medical internship, is not licensed to practice and can’t legally prescribe.   

Of course, Jarvik has been recently defending his status as a scientist and his role in simply educating the public in the ad.  But, his revelation as a past Lipitor® patient, with implied personal endorsement, could certainly make patients feel they’re missing something if they too aren’t taking the compound. 



Of course, we all know the real reason behind the ad.  Pfizer has invested millions hoping Jarvis’s personal endorsement will get patients saying to themselves, “Hey, Dr. Jarvik prescribes it for his patients and takes it himself, how come I’m not on it?”  

The next step they’re hoping for is for them to ask their “prescribing” physician the same thing.  


Well that’s the problem, isn’t it? Lipitor® is a good drug, but it’s not for everyone.  And, only doctors should know what’s best for their own patient’s; right?  

So, should drug companies be held accountable for these ads and/or provide more disclosure to the public?  

In other word’s, should Pfizer have told us that Jarvik isn’t really a doctor, can’t and isn’t prescribing anything to anyone – and wait a second – did he really even take Lipitor® at all?  

Guess only his “prescribing” physician would know, for sure! 


Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com


Product Details  Product Details

Product Details



%d bloggers like this: